Skip to main content

Day: August 3, 2020

Rozlytrek, Roche’s first tumour-agnostic therapy, approved in Europe for people with NTRK fusion-positive solid tumours and for people with ROS1-positive advanced non-small cell lung cancer

Rozlytrek has shown durable responses across multiple tumour types, including cancer that has spread to the brainThis approval shows the value of combining genomic profiling with precision medicine to offer patients with rare and hard-to-treat cancers a personalised treatment option             Basel, 03 August 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission has granted conditional marketing authorisation for Rozlytrek® (entrectinib) for the treatment of adult and paediatric patients 12 years of age and older with solid tumours expressing a neurotrophic tyrosine receptor kinase (NTRK) gene fusion, who have a disease that is locally advanced, metastatic or where surgical resection is likely to result in severe morbidity, and who have not received a prior NTRK inhibitor, who have no satisfactory...

Continue reading

Société Générale : Résultats au 30 juin 2020

 Communiqué de presseParis, le 3 août 2020PERFORMANCE T2-20 ET S1-20 MARQUÉE PAR LA CRISE DU COVID ; REBOND DEPUIS MI-MAIActivités de Banque de Détail en France et Banque de Détail à l’International impactées sur la première partie du T2-20 ; rebond depuis la mi-mai Activités résilientes dans l’Assurance, la Banque Privée et le transaction bankingBonne performance des activités de Financement et Conseil et de Taux, Crédit et Change ; poursuite des conditions de marché défavorables aux produits structurés en avril et mai et reprise progressive depuis mi-maiÉléments exceptionnels non cash liés à la révision de la trajectoire des Activités de Marché et Services aux investisseurs : dépréciation de l’écart d’acquisition pour -684 M EUR et du stock d’impôts différés actifs pour-650 M EURRésultat net part du Groupe à -1 264 M EUR au T2-20 (-1...

Continue reading

Societe Generale: Results at 30 June 2020

 Press releaseParis, August 3rd 2020Q2 20 AND H1 20 PERFORMANCE MARKED BY THE COVID CRISIS; REBOUND FROM MID-MAYFrench Retail Banking and International Retail Banking activities impacted in the first half of Q2 20; rebound from mid-MayResilient activities in Insurance, Private Banking and Transaction BankingGood performance in Financing & Advisory and Fixed Income & Currencies; ongoing unfavourable market conditions for structured products in April and May and gradual recovery from mid-MayNon-cash exceptional items related to the review of the trajectory of Global Markets & Investor Services: impairment of goodwill for EUR -684m and deferred tax assets for EUR -650mGroup net income of EUR -1,264m in Q2 20 (EUR -1,590m in H1 20) and Group net income restated for non-cash exceptional items of EUR +70m in Q2 20

Continue reading

Pretivm Reports Fatality at Brucejack Mine

VANCOUVER, British Columbia, Aug. 02, 2020 (GLOBE NEWSWIRE) — Pretium Resources Inc. (TSX/NYSE:PVG) (“Pretivm” or the “Company”) is deeply saddened to report a fatality resulting from an incident that occurred Friday, July 31st at the Brucejack Mine.The isolated incident occurred during maintenance at a support facility on surface.  The injured employee was treated immediately by the site emergency response team and then transported to the hospital in Terrace, British Columbia where he passed away today.“It is with a heavy heart that I am reporting this tragic loss. Our immediate focus is to support his family, friends and colleagues at this difficult time,” said Jacques Perron, President and CEO of Pretivm.  “The safety and well-being of our employees is our topmost priority and we will investigate the incident fully.  This tragedy...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.